Stimulates respiratory tract secretions Baseline assessment: guaiFENesin by decreasing adhesiveness, viscosity Obtain baseline vital signs, serum Contraindication chemistries. of mucus. Measure pulse, B/P prior to initiation of Generic name: Therapeutic Effect: Promotes removal Contraindications: Hypersensitivity therapy, following dose increases, and of viscous mucus. periodically during therapy. to guaiFENesin. Mucinex Intervention/evaluation Assist with Cautions: Avoid OTC use in children Side Effects ambulation if sedation, dizziness, fatigue, younger than 2 yrs. Classification: lethargy occur. Be alert to mood changes. Abrupt discontinuation may produce Assess for nausea, headache. Monitor B/P, serum chemistries, particularly renal/hepatic PHARMACOTHERAPEUTIC: infrequent, transient elevations in B/P function for change from baseline. Monitor above original baseline (taper dose in daily pattern of bowel activity, stool Respiratory expectorant. decrements of no more than 1 mg consistency. Patient/family teaching every 3– 7 days). Abrupt withdrawal • Avoid tasks that require alertness, motor CLINICAL: Expectorant. following prolonged administration of skills until response to drug is established. • high dosage may produce extreme Avoid alcohol. Route: • Dry mouth may be relieved with sugarless fatigue (may last for wks). Prolonged gum, sips of water. Dosage: 300 mg/dose administration to children may • Advise pts to avoid becoming dehydrated, produce suppression of weight and/or overheated. Frequency: q4 • Do not substitute for immediate-release height patterns. AV block, bradycardia, guanFACINE tablets. arrhythmias occur rarely. • Swallow extended-release tablets whole; do not chew, crush, dissolve, or divide. • Do not take with high-fat meal.